Corporate Update: Market Performance of Emvision Medical Devices and Peer Activity
The share price of Emvision Medical Devices Ltd (ticker EMV.AX) experienced a decline of 3.48 % over the 24‑hour period concluding at 04:26 AM Central European Time on Saturday, 24 April 2026. At the close, a single share was available for purchase at AUD 1.46 on the primary exchanges.
Trading Metrics
- Shares Outstanding: 93 million
- Market Capitalisation: AUD 99.3 million
- Volume (Last 24 h): approximately AUD 43.5 k worth of shares changed hands, indicating modest liquidity relative to the company’s size.
- Recent Trend: The stock has fallen 12.36 % since the close of the previous month.
- Technical Reference: The 200‑day simple moving average stands at AUD 1.68, providing a long‑term benchmark.
- Historical Extremes: The highest price in the past 52 weeks reached AUD 1.96 on 8 May 2026, while the lowest fell to AUD 1.47 on 14 July 2026, underscoring a moderate range of volatility.
Peer Comparison
The broader Australian market provides context for Emvision’s recent movement:
| Stock | 24‑h Performance | Current Price | Market Cap (AUD mn) |
|---|---|---|---|
| Resource Minerals International (RMI.AX) | +13.04 % | 0.12 | 114.2 |
| Nyrada (NYR.AX) | 0 % | 0.44 | 116.4 |
| Elementos (ELT.AX) | +0.63 % | 0.36 | 117.8 |
| Polymetals (POL.AX) | –3.54 % | 0.52 | 117.8 |
| Gorilla Gold Mines (GG8.AX) | –3.12 % | 0.20 | 118.9 |
While Emvision’s decline aligns with a modest dip seen in several peer listings, Resource Minerals International’s robust gain illustrates that market sentiment remains mixed across the sector.
Company Overview
Emvision Medical Devices Ltd, headquartered in Brisbane, specialises in medical imaging and diagnostic services for brain and other organ systems. The company’s operations are confined to the Australian market, with patient access facilitated through its website, www.emvision.com.au . Emvision’s shares are listed on the ASX All Markets, providing institutional and retail investors with a straightforward channel to participate in the company’s growth.
This report is intended to provide investors and market analysts with a concise snapshot of Emvision Medical Devices’ recent trading activity, situating it within the broader Australian market context.
